Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.

Duan W, Gao L, Wu X, Zhang Y, Otterson GA, Villalona-Calero MA.

Exp Cell Res. 2006 Oct 15;312(17):3370-8. Epub 2006 Jul 21.

PMID:
16934800
2.

p53 ubiquitination: Mdm2 and beyond.

Brooks CL, Gu W.

Mol Cell. 2006 Feb 3;21(3):307-15. Review.

3.

A novel oncoprotein Pirh2: rising from the shadow of MDM2.

Wang Z, Yang B, Dong L, Peng B, He X, Liu W.

Cancer Sci. 2011 May;102(5):909-17. doi: 10.1111/j.1349-7006.2011.01899.x. Epub 2011 Feb 28. Review.

4.

ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.

Meulmeester E, Pereg Y, Shiloh Y, Jochemsen AG.

Cell Cycle. 2005 Sep;4(9):1166-70. Epub 2005 Sep 29. Review.

PMID:
16082221
5.
6.

Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.

Jung YS, Qian Y, Chen X.

FEBS Lett. 2012 May 21;586(10):1397-402. doi: 10.1016/j.febslet.2012.03.052. Epub 2012 Apr 3. Review.

7.

[NEGATIVE REGULATORS OF TUMOR SUPPRESSOR P53 IN THE CONTEXT OF ANTICANCER THERAPY].

Shuvalov OY, Fedorova OA, Petukhov AV, Daks AA, Vasilieva EA, Grigorieva TA, Ivanov GS, Barlev NA.

Tsitologiia. 2015;57(12):847-54. Review. Russian.

PMID:
26995961
8.

Mdm2 links genotoxic stress and metabolism to p53.

Wang Z, Li B.

Protein Cell. 2010 Dec;1(12):1063-72. doi: 10.1007/s13238-010-0140-9. Epub 2011 Jan 8. Review.

9.

Pirh2: an E3 ligase with central roles in the regulation of cell cycle, DNA damage response, and differentiation.

Halaby MJ, Hakem R, Hakem A.

Cell Cycle. 2013 Sep 1;12(17):2733-7. doi: 10.4161/cc.25785. Epub 2013 Aug 5. Review.

10.

Regulation of MDM2 Stability After DNA Damage.

Li J, Kurokawa M.

J Cell Physiol. 2015 Oct;230(10):2318-27. doi: 10.1002/jcp.24994. Review.

PMID:
25808808
11.

Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

Marine JC, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G.

Cell Death Differ. 2006 Jun;13(6):927-34. Review. No abstract available.

12.

A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.

Satija YK, Bhardwaj A, Das S.

Int J Cancer. 2013 Dec 15;133(12):2759-68. doi: 10.1002/ijc.28129. Epub 2013 Mar 25. Review.

13.

The role of ubiquitination in the direct mitochondrial death program of p53.

Marchenko ND, Moll UM.

Cell Cycle. 2007 Jul 15;6(14):1718-23. Epub 2007 May 25. Review.

PMID:
17630506
14.

Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destruction.

Inuzuka H, Fukushima H, Shaik S, Wei W.

Oncotarget. 2010 Nov;1(7):685-90. Review.

15.

Making sense of ubiquitin ligases that regulate p53.

Jain AK, Barton MC.

Cancer Biol Ther. 2010 Oct 1;10(7):665-72. Epub 2010 Oct 1. Review.

16.

p53 ubiquitination by Mdm2: a never ending tail?

Coutts AS, Adams CJ, La Thangue NB.

DNA Repair (Amst). 2009 Apr 5;8(4):483-90. doi: 10.1016/j.dnarep.2009.01.008. Epub 2009 Feb 12. Review.

PMID:
19217357
17.

Regulation of the p53 response and its relationship to cancer.

Meek DW.

Biochem J. 2015 Aug 1;469(3):325-46. doi: 10.1042/BJ20150517. Review.

PMID:
26205489
18.

Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review.

Shaikh MF, Morano WF, Lee J, Gleeson E, Babcock BD, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB.

Ann Clin Lab Sci. 2016 Dec;46(6):627-634. Review.

PMID:
27993876
19.

Oscillations by the p53-Mdm2 feedback loop.

Lahav G.

Adv Exp Med Biol. 2008;641:28-38. Review.

PMID:
18783169
20.

[Multifunctionality of MDM2 protein and its role in genomic instability of cancer cells].

MaƂuszek M.

Postepy Biochem. 2015;61(1):42-51. Review. Polish.

Supplemental Content

Support Center